SUBSCRIBE
SUBSCRIBE
News   FDA

FDA Panel Urges More Testing for Diabetes Drugs

July 28, 2008 | 
1 min read
NEW YORK (Associated Press) - Diabetes drugs should face tougher safety standards that could cost manufacturers millions but protect patients from unforeseen heart risks, a government panel has recommended.
FDA Approvals Regulatory
MORE ON THIS TOPIC
Illustration of a yellow envelope on a blue background with a read warning symbol
Manufacturing
FDA issues warning over Eurofins’ selective recording that ‘compromises’ data
October 16, 2026
 · 
2 min read
 · 
Nick Paul Taylor
Chain of arrows blocks. Consistency and focus. Concept of conformism, vertical of power. Unchanging course of development. Moving forward. Education and skill growth. Building a solid strategy.
FDA
FDA’s latest rare disease framework seeks to prioritize consistency in flexibility
October 15, 2026
 · 
4 min read
 · 
Michael Gibney
Overcome crises with the patience of a visionary leader. Business team surfing sea waves with paper boats vector
Cancer
RevMed’s Rasonque gets a subtype data asterisk, but analysts remain bullish
October 12, 2026
 · 
3 min read
 · 
Michael Gibney
IN PARTNERSHIP WITH ROSE BIOSOLUTIONS
Successful CDMO partnerships hinge on honest—and sometimes critical—support
October 12, 2026
 · 
5 min read
 · 
Jennifer C. Smith-Parker